{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:54:23Z","timestamp":1792788863841,"version":"4.5.0"},"reference-count":40,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Background: Fabry disease (FD) is a genetic disorder caused by lysosomal \u03b1-galactosidase-A deficiency and is characterized by the systemic accumulation of globotriaosylceramide. All endocrine glands are susceptible to globotriaosylceramide accumulation because of their high vascularization and low cellular proliferation rate. Nevertheless, this endocrine system has never been investigated in detail.<\/jats:p>\n               <jats:p>Objective: We aimed to investigate the function and morphology of the endocrine glands in FD.<\/jats:p>\n               <jats:p>Patients: The thyroid, gonadal, adrenal, and GH\/IGF-I axes were evaluated in 18 FD patients (nine females and nine males, aged 21\u201364 yr) and 18 sex- and age-matched healthy subjects.<\/jats:p>\n               <jats:p>Study design: We conducted an observational, analytical, open, prospective study.<\/jats:p>\n               <jats:p>Interventions: Ten of the 18 patients received enzyme replacement therapy (ERT) with recombinant human \u03b1-galactosidase-A (agalsidase \u03b2) at a dose of 1 mg\/kg body weight every 2 wk.<\/jats:p>\n               <jats:p>Results: FD patients had higher baseline TSH levels than controls (P &amp;lt; 0.01). Three subjects were diagnosed with an early stage of subclinical primary hypothyroidism associated with negative antithyroid antibodies. A history of menses abnormalities, miscarriage, or assisted delivery was found in 89% of FD women. Asthenozoospermia, oligozoospermia, or both were found in all FD men through seminal fluid analysis. FD patients had significantly higher circulating ACTH and lower cortisol levels than controls (P &amp;lt; 0.05). In patients under ERT, a suboptimal cortisol response to the 250-\u03bcg ACTH test was found in 10%, and the ACTH-stimulated cortisol peak was significantly correlated to the health status profile (P &amp;lt; 0.05).<\/jats:p>\n               <jats:p>Conclusion: A variety of latent endocrine dysfunctions, including life-threatening conditions, occur in patients with FD. Endocrine dysfunctions are also present in patients already receiving ERT and are in part related to their persistent poor quality of life. An endocrine work-up should be recommended in all FD patients. Adequate monitoring and hormonal therapy, when required, have to be performed in cases of subclinical endocrine dysfunction to avoid life-threatening events.<\/jats:p>","DOI":"10.1210\/jc.2006-0858","type":"journal-article","created":{"date-parts":[[2006,8,23]],"date-time":"2006-08-23T03:44:04Z","timestamp":1156304644000},"page":"4319-4325","source":"Crossref","is-referenced-by-count":46,"title":["Endocrine Dysfunction in Patients with Fabry Disease"],"prefix":"10.1210","volume":"91","author":[{"given":"A.","family":"Faggiano","sequence":"first","affiliation":[{"name":"Departments of Molecular and Clinical Endocrinology and Oncology (A.F., F.M., M.G., M.F., G.L., A.C.), 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pisani","sequence":"additional","affiliation":[{"name":"Nephrology (A.P., M.S., B.C.), 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Milone","sequence":"additional","affiliation":[{"name":"Departments of Molecular and Clinical Endocrinology and Oncology (A.F., F.M., M.G., M.F., G.L., A.C.), 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gaccione","sequence":"additional","affiliation":[{"name":"Departments of Molecular and Clinical Endocrinology and Oncology (A.F., F.M., M.G., M.F., G.L., A.C.), 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Filippella","sequence":"additional","affiliation":[{"name":"Departments of Molecular and Clinical Endocrinology and Oncology (A.F., F.M., M.G., M.F., G.L., A.C.), 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Santoro","sequence":"additional","affiliation":[{"name":"Departments of Molecular and Clinical Endocrinology and Oncology (A.F., F.M., M.G., M.F., G.L., A.C.), 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Vallone","sequence":"additional","affiliation":[{"name":"Radiology (F.T., A.S., G.V.), 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Tortora","sequence":"additional","affiliation":[{"name":"Radiology (F.T., A.S., G.V.), 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sabbatini","sequence":"additional","affiliation":[{"name":"Nephrology (A.P., M.S., B.C.), 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Spinelli","sequence":"additional","affiliation":[{"name":"Internal Medicine (L.S.), \u201cFederico II\u201d University of Naples, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lombardi","sequence":"additional","affiliation":[{"name":"Departments of Molecular and Clinical Endocrinology and Oncology (A.F., F.M., M.G., M.F., G.L., A.C.), 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Cianciaruso","sequence":"additional","affiliation":[{"name":"Nephrology (A.P., M.S., B.C.), 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Colao","sequence":"additional","affiliation":[{"name":"Departments of Molecular and Clinical Endocrinology and Oncology (A.F., F.M., M.G., M.F., G.L., A.C.), 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613381318600_R1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1651-2227.2002.tb03102.x","article-title":"Angiokeratoma corporis diffusum\u2013Fabry disease: historical review from the original description to the introduction of enzyme replacement therapy","volume":"91","author":"Fabry","year":"2002","journal-title":"Acta Paediatr Suppl"},{"key":"2020071613381318600_R2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1651-2227.2002.tb03104.x","article-title":"Cardiac involvement in Fabry disease","volume":"91","author":"Linhart","year":"2002","journal-title":"Acta Paediatr Suppl"},{"key":"2020071613381318600_R3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000059897","article-title":"Kidney involvement in Anderson-Fabry disease","volume":"122","author":"Meroni","year":"1997","journal-title":"Contrib Nephrol"},{"key":"2020071613381318600_R4","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1212\/WNL.50.6.1746","article-title":"Quantitative analysis of cerebral vasculopathy in patients with Fabry disease","volume":"50","author":"Crutchfield","year":"1998","journal-title":"Neurology"},{"key":"2020071613381318600_R5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000106640","article-title":"The vascular dementia of Fabry\u2019s disease","volume":"8","author":"Mendez","year":"1997","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2020071613381318600_R6","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00006231-199809000-00009","article-title":"Gastrointestinal symptoms and delayed gastric emptying in Fabry\u2019s disease: response to metoclopramide","volume":"19","author":"Argoff","year":"1998","journal-title":"Nucl Med Commun"},{"key":"2020071613381318600_R7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"2020071613381318600_R8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"2020071613381318600_R9","first-page":"11","article-title":"Natural history of Fabry disease in affected males and obligate carrier females","author":"MacDermot","year":"2001","journal-title":"J Inherit Metab Dis 24(Suppl 2):13\u201314; discussion"},{"key":"2020071613381318600_R10","first-page":"259","article-title":"Fabry disease: a metabolic disorder with a challenge for endocrinologists?","volume":"58","author":"Feldt-Rasmussen","year":"2002","journal-title":"Horm Res"},{"key":"2020071613381318600_R11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/path.1711410203","article-title":"Testicular and epididymal involvement in Fabry\u2019s disease","volume":"141","author":"Nistal","year":"1983","journal-title":"J Pathol"},{"key":"2020071613381318600_R12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2169\/internalmedicine.33.172","article-title":"Possible thyroidal involvement in a case of Fabry disease","volume":"33","author":"Tojo","year":"1994","journal-title":"Intern Med"},{"key":"2020071613381318600_R13","first-page":"88","article-title":"Fabry disease: correction of the enzymatic deficiency by renal transplantation","volume":"9","author":"Desnick","year":"1973","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"2 Suppl 1","key":"2020071613381318600_R14","first-page":"S1","article-title":"Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2020071613381318600_R15","first-page":"1615","article-title":"Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults","volume":"83","author":"Aimaretti","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613381318600_R16","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2002-021558","article-title":"Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing\u2019s disease during active disease and 1 year after disease remission","volume":"88","author":"Faggiano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613381318600_R17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1023\/A:1008878031176","article-title":"The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adults","volume":"7","author":"Ware Jr","year":"1998","journal-title":"Qual Life Res"},{"key":"2020071613381318600_R18","year":"1999"},{"key":"2020071613381318600_R19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1152\/physrev.1992.72.3.667","article-title":"Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors","volume":"72","author":"Dumont","year":"1992","journal-title":"Physiol Rev"},{"key":"2020071613381318600_R20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1399-0004.2004.00284.x","article-title":"Enzyme replacement therapy with agalsidase \u03b2 improves cardiac involvement in Fabry\u2019s disease","volume":"66","author":"Spinelli","year":"2004","journal-title":"Clin Genet"},{"key":"2020071613381318600_R21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.ajkd.2005.03.016","article-title":"Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement","volume":"46","author":"Pisani","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"2020071613381318600_R22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/B:BOLI.0000028726.11177.8b","article-title":"Clinical benefit in Fabry patients given enzyme replacement therapy: a case series","volume":"27","author":"Guffon","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"2020071613381318600_R23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(04)15696-1","article-title":"Hypothyroidism","volume":"363","author":"Roberts","year":"2004","journal-title":"Lancet"},{"key":"2020071613381318600_R24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/08916930410001705466","article-title":"Addison\u2019s disease","volume":"37","author":"Marzotti","year":"2004","journal-title":"Autoimmunity"},{"key":"2020071613381318600_R25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/milmed\/141.4.259","article-title":"Diffuse angiokeratoma (Fabry\u2019s disease): case report","volume":"141","author":"Guin","year":"1976","journal-title":"Mil Med"},{"key":"2020071613381318600_R26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10545-005-0003-3","article-title":"High prevalence of subclinical hypothyroidism in patients with Anderson-Fabry disease","volume":"28","author":"Hauser","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"2020071613381318600_R27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2265.2003.01681.x","article-title":"Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease","volume":"58","author":"Demers","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613381318600_R28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/105072503321086962","article-title":"Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease","volume":"13","author":"Baloch","year":"2003","journal-title":"Thyroid"},{"key":"2020071613381318600_R29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/thy.2000.10.251","article-title":"The value of ultrasonography in predicting autoimmune thyroid disease","volume":"10","author":"Pedersen","year":"2000","journal-title":"Thyroid"},{"key":"2020071613381318600_R30","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1742-1241.2005.00620.x","article-title":"Hormonal profile and fertility in patients with Anderson-Fabry disease","volume":"59","author":"Hauser","year":"2005","journal-title":"Int J Clin Pract"},{"key":"2020071613381318600_R31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1530\/acta.0.0930277","article-title":"Dissociation of pituitary glycoprotein response to releasing hormones in chronic renal failure","volume":"93","author":"LeRoith","year":"1980","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071613381318600_R32","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1210\/jcem-50-5-846","article-title":"Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure","volume":"50","author":"Sievertsen","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613381318600_R33","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1161\/01.STR.32.7.1559","article-title":"Enhanced endothelium-dependent vasodilation in Fabry disease","volume":"32","author":"Altarescu","year":"2001","journal-title":"Stroke"},{"key":"2020071613381318600_R34","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1001\/jama.284.21.2771","article-title":"Clinical features of and recent advances in therapy for Fabry disease","volume":"284","author":"Brady","year":"2000","journal-title":"JAMA"},{"key":"2020071613381318600_R35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/j.1939-4640.1985.tb00826.x","article-title":"Stagnation of blood in the microcirculatory vessels in the testes of men with varicocele","volume":"6","author":"Chakraborty","year":"1985","journal-title":"J Androl"},{"key":"2020071613381318600_R36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.fertnstert.2003.05.019","article-title":"Intraovarian blood flow measured with color Doppler ultrasonography inversely correlates with vascular density in the human corpus luteum of the menstrual cycle","volume":"81","author":"Ottander","year":"2004","journal-title":"Fertil Steril"},{"key":"2020071613381318600_R37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1210\/edrv-9-2-267","article-title":"Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone","volume":"9","author":"Ying","year":"1988","journal-title":"Endocr Rev"},{"key":"2020071613381318600_R38","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM199610173351607","article-title":"Adrenal insufficiency","volume":"335","author":"Oelkers","year":"1996","journal-title":"N Engl J Med"},{"key":"2020071613381318600_R39","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00006254-199911000-00023","article-title":"Acute adrenal insufficiency during pregnancy and puerperium: case report and literature review","volume":"54","author":"Perlitz","year":"1999","journal-title":"Obstet Gynecol Surv"},{"key":"2020071613381318600_R40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jms.7.3.127","article-title":"Maternal thyroid deficiency and pregnancy complications: implications for population screening","volume":"7","author":"Allan","year":"2000","journal-title":"J Med Screen"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/91\/11\/4319\/9061157\/jcem4319.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/91\/11\/4319\/9061157\/jcem4319.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:17:10Z","timestamp":1594945030000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/91\/11\/4319\/2656422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,1]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2006-0858","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,1]]}}}